The Vanguard
Utility

Using Blow-Fill-Seal to Reliably Provide Drugs Often in Shortage

The Vanguard Utility is an independent company spun off from Apiject to help commercialize Blow-Fill-Seal for a wide range of liquid pharmaceuticals.

The Vanguard Utility, and its sister companies the Global Pharmaceutical Reserve and the Pharmaceutical Reserve Network, is focused on making sure more hospitals and patients can procure the liquid medicines they urgently need but cannot reliably get from other suppliers.

With its facility in North Carolina, Vanguard develops or procures generic liquid pharmaceuticals, packages them using BFS, and sells them directly to hospitals and pharmacies under U.S. FDA 503B regulations. Although it is a new company, Vanguard will soon be able to reliably provide dozens of generic liquid medicines that are often in shortage — and do so at very reasonable prices.

Explore Vanguard’s Services

To learn more about Vanguard and its sister companies, visit their website or contact them at [email protected].

Visit Vanguard

Apiject Technology Development Center Expert Resources

View All
Apiject to Open New U.S. Generic Injectable Drug Manufacturing Facility in Apex, North Carolina
30,000-Square-Foot Facility Will Advance America’s Priority to Reshore Essential Drug Manufacturing APEX, NC, January 16, 2026 — Apiject Holdings, Inc. today announced the signing of a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The facility will house two…
Partnering for Success
We help pharma companies fill-finish sterile liquids by working together to create Blow-Fill-Seal based, prefilled drug delivery systems, and then assist in the fill-finish process. The result is a prefilled drug delivery system that can be flexibly manufactured at various facilities that…
Apiject Announces Proof-of-Concept in Blow-Fill-Seal at Orlando Technology Development Center – Opportunity to “Test Drive” Apiject Technology –
Orlando, FL, February 28, 2024 – Apiject Systems, Corp., a medical technology public-benefit corporation, announced it has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS)…
Apiject Technology Development Center
The Apiject Technology Development Center in greater Orlando, Florida is focused on helping pharmaceutical companies prepare their drug product for high-speed, high-volume production in a new type of scalable prefilled syringe that is made largely using the Blow-Fill- Seal aseptic process.

Related Video Content

View All
Test Drive Our Technology
Did You Know? Drug Stability Testing & Blow-Fill-Seal
Intro to Blow-Fill-Seal / Chapter 10: Cost Efficiency

Get in Touch!

Contact us today to learn more about Apiject and easy first steps to see if our Platform may be right for your sterile liquid product.

Contact Us